Expression of Concern: WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: A phase 2, randomized, double blind, placebo controlled study
Expression of Concern: WR279,396, a third generation aminoglycoside ointment for the treatment of Leishmania major cutaneous leishmaniasis: A phase 2, randomized, double blind, placebo controlled study
Authors
- The PLOS Neglected Tropical Diseases Editors
Publication Details
- Journal
- PLoS neglected tropical diseases
- Published
- 2026-03-05
- DOI
- https://doi.org/10.1371/journal.pntd.0014047
- Primary Topic
- Research on Leishmaniasis Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00